期刊文献+

重组牛碱性成纤维细胞生长因子眼液用于鼻内镜术后患者治疗体会 被引量:1

暂未订购
导出
摘要 目的:探讨重组牛碱性成纤维细胞生长因子眼液(贝复舒)在鼻内镜术后的应用价值。方法:选取130例鼻内镜鼻窦手术患者,术后按照随机数字表法随机分为观察组(贝复舒组)和对照组各65例,比较两组患者术后术腔黏膜恢复情况。结果:观察组完全上皮化时间为(28.6±7.3)d,6个月后总有效率为96.9%;对照组完全上皮化时间为(49.2±10.4)d,6个月后总有效率为78.5%;两组患者完全上皮化时间与6个月后总有效率比较,差异均有统计学意义(t=15.263,χ2=23.147,P<0.01)。两组患者均未出现明显不良反应情况。结论:重组牛碱性成纤维细胞生长因子眼液(贝复舒)在鼻内镜术后填塞鼻腔可以有效的促进鼻腔黏膜的恢复,且用药安全,值得推广应用。
作者 项锦银
出处 《吉林医学》 CAS 2012年第26期5657-5657,共1页 Jilin Medical Journal
  • 相关文献

参考文献3

二级参考文献16

  • 1Passali D,Passali FM,Damiani V,et al.Treatment of inferior turbinate hypertrophy:a randomized clinical trial[J].Ann Otol Rhinol Laryngol,2003,112(8):683-688.
  • 2Ritter C A, Arteaga C L. The epidermal growth factor receptor- tyrosine kinase: a promising therapeutic target in solid tumors [ J ]. Semin Oncol, 2003,30 ( 1 ) : 3-11.
  • 3Mok T S, Wu Y L, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma [J]. N Engl J Med, 2009,361 (10) :947-957.
  • 4Perez-Soler R, Sahz L. Cutaneous adverse effects with HERI! EGFR-targeted agents: is there a silver lining [J]? J Clin Oncol, 2005,23 (22) : 5235-5246.
  • 5Perez-Soler R, Delord J P, Halpern A, et al. HERI/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum [J]. Oncologist, 2005,10(3) :345-356.
  • 6Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors [J]. Ann Oncol, 2005,16(9) : 1425-1433.
  • 7Laeouture M E, Lai S E. The PRIDE (papulopustules and/or paronychia, regulatory abnormalities of hair growth, itching, and dryness due to epidermal growth factor receptor inhibitors) syndrome [J]. Br J Dermatol, 2006, 155 (6) : 852-854.
  • 8Albanell J, Rojo F, Averbuch S, et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition [J]. J Clin Oncol,2002,20 (1):110-124.
  • 9Cragg M S, Kuroda J, Puthalakath H, etal. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics [J]. PLoS Med, 2007,4(10) : 1681-1689.
  • 10Dreyfuss D,Saumon G.Ventilatorinduced lung injury lesso n s from experimental studies[J].Am J Respir Crit Care Med,1998,157:294-323.

共引文献84

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部